Liver metastases in prostate carcinoma represent a relatively aggressive subtype refractory to hormonal therapy and short-duration response to docetaxel monotherapy
Arsh Singh, Naga K.S. Cheedella, Shams A. Shakil, Frederick Gulmi, Dong Sung Kim, Jen C. Wang
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Liver metastases in prostate carcinoma represent a relatively aggressive subtype refractory to hormonal therapy and short-duration response to docetaxel monotherapy'. Together they form a unique fingerprint.